JohnTHoranMD

Oncology • Boston, MA

Physician

Join to view full profile

Dr. Horan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Horan's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-3270

Fax+1 617-632-4410

Education & Training

University of RochesterFellowship, Pediatric Hematology/Oncology, 1998 - 2000
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1997 - 1998
University of RochesterResidency, Pediatrics, 1993 - 1996
Rutgers New Jersey Medical SchoolClass of 1993

Certifications & Licensure

NY State Medical License 1996 - 2026
MA State Medical License 2012 - 2025
GA State Medical License 2004 - 2021
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver Start of enrollment: 2005 Nov 01
No longer available
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD) Start of enrollment: 2007 Apr 01
Completed
Phase 1
Intraosseous Infusion of Unrelated Cord Blood Grafts Start of enrollment: 2007 Mar 01
Terminated
Not Applicable
Sickle Cell Disease Conditioning for Bone Marrow Transplant Start of enrollment: 2009 Feb 01
Completed
Phase 1
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2010 Sep 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

116 citations
Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research
Julie A. Panepinto, Mark C. Walters, Jeanette Carreras, Judith C. W. Marsh, Christopher Bredeson
British Journal of Haematology. 2007-06-01
56 citations
Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: The C...
Donna A. Wall, Shelly L. Carter, Nancy A. Kernan, Neena Kapoor, Naynesh Kamani
Biology of Blood and Marrow Transplantation. 2005-08-01
21 citations
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
Muna Qayed, Ben Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz
Blood Advances. 2021-11-09

Journal Articles

Treatment Strategies for Adolescent and Young Adult Patients with Acute Myeloid Leukemia
John T Horan, David R Freyer, Blood

Abstracts/Posters

Pediatric Hematologist/OncologistsÍ Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Resea...
John T. Horan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Transcriptomic Analysis of CD4+ T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28...
John T. Horan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

UR Medicine Golisano Children’s Hospital to Lead Groundbreaking Sickle Cell Treatment StudyNovember 6th, 2024